Article Listing - Spain’s Almirall sees third-quarter 2009 sales up 2.4%, with strong showing from dermatologicals

EXPANSION AT SILESIA IN CHILE

13 April 1992

The Chilean pharmaceutical comp-any Silesia is continuing to expand at is base in Santiago. The company its currently working on...

ROCHE'S LAZABEMIDE IN PHASE III NEXT YEAR

13 April 1992

Hoffmann-La Roche has indicated that it expects to begin Phase III trials with its mono-amine oxidase type B-selective inhibitor lazabemide...

SAFER TRAVELLER'S DIARRHEA DRUG

13 April 1992

A safer treatment for traveller's diarrhea may soon be available, which will be suitable for use by adults, children and...

DEPRESSION: THE COST TO SOCIETY

6 April 1992

The costs of depression to the National Health Service in the UK are L 333 million per year, according to...

ROBERTS PHARMA ACQUIRES NCRC

6 April 1992

The US concern Roberts Pharma-ceutical has reached a definitive agreement to acquire the National Clinical Research Centers in the USA...

GLAXO FRANCE CHIEF QUITS

6 April 1992

Edwin Nathan, president of Glaxo France and of the group's Belgian and Luxembourg companies, has announced his departure from the...

PROFITS UP AT ITALIAN SORIN BIOMEDICA IN 1991

6 April 1992

Sorin Biomedica made net profits in 1991 of 12.3 billion lire ($9.9 billion), up from 11 billion lire in the...

EPIC REGISTRATION NOW OVER 1,300

6 April 1992

Speaking at the 12th International Symposium on Intensive Care and Emergency Medicine in Brussels, late last month, Andre Heyns, Roussel-...

INTERFERON ALFA-N3 AND AIDS

6 April 1992

Researchers at the Walter Reed Army Institute of Research and at Interferon Sciences have commenced Phase I trials with the...

PA CONSULTING GROUP APPOINTMENTS

6 April 1992

Appointed as senior associates for the pharmaceutical industry at PA Consulting Group are Keith Mansford, former chairman of R&D...

Showing 94581-94590 of 95558 articles

Go to beginningPreviousNextGo to end